Symbol
MDT
ISIN
IE00BTN1Y115
Börse
NYSE
Sektor
Health Care
Marktkapitalisierung
159.248 Mrd. US
Branche
Health Care Equipment & Supplies
Dividendenrendite
1.99 %
Ausschüttungsquote
62.3 %
KGV
43.18
KUV (TTM)
5.66
KGVe
20.00
Kursziel
129.29 USD
Symbol
MDT
ISIN
IE00BTN1Y115
Börse
NYSE
Marktkapitalisierung
159.248 Mrd. USD
Sektor
Health Care
Branche
Health Care Equipment & Supplies
Dividendenrendite
1.99 %
Ausschüttungsquote
62.3 %
KGV
43.18
KUV (TTM)
5.66
KGVe
20.00
Kursziel
129.29 USD
Live-Chart (verzögert)
Firmenbeschreibung
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Minimally Invasive Therapies Group segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, hernia mechanical devices, mesh implants, and gynecology products; electrosurgical hardware and instruments, and mesh fixation devices; and gastrointestinal, inhalation therapy, and renal care solutions. The Restorative Therapies Group segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; colorectal surgeons; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The Diabetes Group segment offers insulin pumps and consumables, and continuous glucose monitoring systems. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Medtronic plc Fundamentaldaten
Jahre und Quartale beziehen sich jeweils auf das Geschäftsjahr des Unternehmens. (Das Geschäftsjahr kann ggf. vom Kalenderjahr abweichen.)
Das Geschäftsjahr von Medtronic plc endet im April.
Gewinn pro Jahr & Quartal (Net Income) in Mrd. USD
Q1 Mai-Jul |
Q2 Aug-Okt |
Q3 Nov-Jan |
Q4 Feb-Apr |
Jahr Mai-Apr |
|
---|---|---|---|---|---|
2021 | 0.487 | 0.489 | 0.000 | 0.000 | 0.976 |
2020 | 0.864 | 1.364 | 1.915 | 0.646 | 4.789 |
2019 | 1.075 | 1.115 | 1.269 | 1.172 | 4.631 |
2018 | 1.016 | 2.017 | -1.389 | 1.460 | 3.104 |
2017 | 0.929 | 1.115 | 0.821 | 1.163 | 4.028 |
2016 | 0.820 | 0.520 | 1.095 | 1.103 | 3.538 |
2015 | 0.871 | 0.828 | -0.037 | 1.698 | 3.360 |
2014 | 0.953 | 0.902 | 0.762 | 0.448 | 3.065 |
2013 | 0.864 | 0.646 | 0.988 | 0.969 | 3.467 |
2012 | 0.821 | 0.871 | 0.934 | 0.991 | 3.617 |
2011 | 0.830 | 0.566 | 0.924 | 0.776 | 3.096 |
2010 | 0.445 | 0.869 | 0.831 | 0.954 | 3.099 |
Gewinn je Aktie (EPS) pro Jahr & Quartal (non-GAAP)
Q1 Mai-Jul |
Q2 Aug-Okt |
Q3 Nov-Jan |
Q4 Feb-Apr |
Jahr Mai-Apr |
|
---|---|---|---|---|---|
2021 | 0.62 | 1.02 | 0 | 0 | 1.64 |
2020 | 1.26 | 1.31 | 1.44 | 0.58 | 4.59 |
2019 | 1.17 | 1.22 | 1.29 | 1.54 | 5.22 |
2018 | 1.12 | 1.07 | 1.17 | 1.42 | 4.78 |
2017 | 1.03 | 1.12 | 1.12 | 1.33 | 4.6 |
2016 | 1.02 | 1.03 | 1.06 | 1.27 | 4.38 |
2015 | 0.93 | 0.96 | 1.01 | 1.16 | 4.06 |
2014 | 0.88 | 0.91 | 0.91 | 1.12 | 3.82 |
2013 | 0.85 | 0.88 | 0.93 | 1.1 | 3.76 |
2012 | 0.79 | 0.84 | 0.84 | 0.99 | 3.46 |
2011 | 0.8 | 0.82 | 0.86 | 0.9 | 3.38 |
2010 | 0.79 | 0.77 | 0.77 | 0.9 | 3.23 |
Umsatz pro Jahr & Quartal in Mrd. USD
Q1 Mai-Jul |
Q2 Aug-Okt |
Q3 Nov-Jan |
Q4 Feb-Apr |
Jahr Mai-Apr |
|
---|---|---|---|---|---|
2021 | 7.493 | 7.647 | 0 | 0 | 15.14 |
2020 | 7.384 | 7.706 | 7.717 | 5.997 | 28.804 |
2019 | 7.384 | 7.481 | 7.546 | 8.146 | 30.557 |
2018 | 7.39 | 7.05 | 7.369 | 8.144 | 29.953 |
2017 | 7.166 | 7.345 | 7.283 | 7.916 | 29.71 |
2016 | 7.274 | 7.058 | 6.934 | 7.567 | 28.833 |
2015 | 4.273 | 4.366 | 4.318 | 7.304 | 20.261 |
2014 | 4.083 | 4.194 | 4.163 | 4.565 | 17.005 |
2013 | 4.008 | 4.095 | 4.027 | 4.46 | 16.59 |
2012 | 3.946 | 4.023 | 3.918 | 4.297 | 16.184 |
2011 | 3.773 | 3.711 | 3.857 | 4.167 | 15.508 |
2010 | 3.951 | 3.838 | 3.85 | 4.196 | 15.835 |
Umsatz je Aktie pro Jahr & Quartal
Q1 Mai-Jul |
Q2 Aug-Okt |
Q3 Nov-Jan |
Q4 Feb-Apr |
Jahr Mai-Apr |
|
---|---|---|---|---|---|
2021 | 5.55 | 5.66 | 0.00 | 0.00 | 210.28 |
2020 | 5.44 | 5.70 | 5.71 | 4.44 | 21.30 |
2019 | 5.40 | 5.48 | 5.54 | 6.02 | 22.58 |
2018 | 5.31 | 5.12 | 5.39 | 6.01 | 22.12 |
2017 | 5.03 | 5.22 | 5.23 | 5.72 | 21.48 |
2016 | 6.56 | 4.92 | 4.85 | 5.32 | 20.28 |
2015 | 4.21 | 4.34 | 4.35 | 7.33 | 20.34 |
2014 | 3.97 | 4.11 | 4.13 | 4.52 | 16.84 |
2013 | 3.78 | 3.95 | 3.92 | 4.37 | 16.25 |
2012 | 3.65 | 3.76 | 3.69 | 4.05 | 15.27 |
2011 | 3.40 | 3.40 | 3.56 | 3.87 | 14.39 |
2010 | 3.51 | 3.44 | 3.47 | 3.78 | 14.28 |
Gewinn-Wachstum in Prozent
Q1 Mai-Jul |
Q2 Aug-Okt |
Q3 Nov-Jan |
Q4 Feb-Apr |
Jahr Mai-Apr |
|
---|---|---|---|---|---|
2021 | -24.61 | 0.41 | -100.00 | 0.00 | -79.62 |
2020 | -26.28 | 57.87 | 40.40 | -66.27 | 3.41 |
2019 | -26.37 | 3.72 | 13.81 | -7.64 | 49.19 |
2018 | -12.64 | 98.52 | -168.86 | 0.00 | -22.94 |
2017 | -15.78 | 20.02 | -26.37 | 41.66 | 13.85 |
2016 | -51.71 | -36.59 | 110.58 | 0.73 | 5.30 |
2015 | 94.42 | -4.94 | -104.48 | 0.00 | 9.62 |
2014 | -1.65 | -5.35 | -15.52 | -41.21 | -11.60 |
2013 | -12.82 | -25.23 | 52.94 | -1.92 | -4.15 |
2012 | 5.80 | 6.09 | 7.23 | 6.10 | 16.83 |
2011 | -13.00 | -31.81 | 63.25 | -16.02 | -0.10 |
2010 | 332.04 | 95.28 | -4.37 | 14.80 | 49.71 |
Umsatz-Wachstum in Prozent
Q1 Mai-Jul |
Q2 Aug-Okt |
Q3 Nov-Jan |
Q4 Feb-Apr |
Jahr Mai-Apr |
|
---|---|---|---|---|---|
2021 | 24.95 | 2.06 | 0.00 | 0.00 | 0.00 |
2020 | -9.35 | 4.36 | 0.14 | -22.29 | -5.74 |
2019 | -9.33 | 1.31 | 0.87 | 7.95 | 2.02 |
2018 | -6.64 | -4.60 | 4.52 | 10.52 | 0.82 |
2017 | -5.30 | 2.50 | -0.84 | 8.69 | 3.04 |
2016 | -0.41 | -2.97 | -1.76 | 9.13 | 42.31 |
2015 | -6.40 | 2.18 | -1.10 | 69.15 | 19.15 |
2014 | -8.45 | 2.72 | -0.74 | 9.66 | 2.50 |
2013 | -6.73 | 2.17 | -1.66 | 10.75 | 2.51 |
2012 | -5.30 | 1.95 | -2.61 | 9.67 | 4.36 |
2011 | -10.08 | -1.64 | 3.93 | 8.04 | -2.07 |
2010 | 3.19 | -2.86 | 0.31 | 8.99 | 8.47 |
Medtronic plc Fundamentaldaten
Gewinn pro Jahr & Quartal (Net Income)
Q1 Mai-Jul |
Q2 Aug-Okt |
Q3 Nov-Jan |
Q4 Feb-Apr |
Jahr Mai-Apr |
|
---|---|---|---|---|---|
2021 | 0.487 | 0.489 | 0.000 | 0.000 | 0.976 |
2020 | 0.864 | 1.364 | 1.915 | 0.646 | 4.789 |
2019 | 1.075 | 1.115 | 1.269 | 1.172 | 4.631 |
2018 | 1.016 | 2.017 | -1.389 | 1.460 | 3.104 |
2017 | 0.929 | 1.115 | 0.821 | 1.163 | 4.028 |
2016 | 0.820 | 0.520 | 1.095 | 1.103 | 3.538 |
2015 | 0.871 | 0.828 | -0.037 | 1.698 | 3.360 |
2014 | 0.953 | 0.902 | 0.762 | 0.448 | 3.065 |
2013 | 0.864 | 0.646 | 0.988 | 0.969 | 3.467 |
2012 | 0.821 | 0.871 | 0.934 | 0.991 | 3.617 |
2011 | 0.830 | 0.566 | 0.924 | 0.776 | 3.096 |
2010 | 0.445 | 0.869 | 0.831 | 0.954 | 3.099 |
Gewinn je Aktie (EPS) pro Jahr & Quartal (non-GAAP)
Q1 Mai-Jul |
Q2 Aug-Okt |
Q3 Nov-Jan |
Q4 Feb-Apr |
Jahr Mai-Apr |
|
---|---|---|---|---|---|
2021 | 0.62 | 1.02 | 0 | 0 | 1.64 |
2020 | 1.26 | 1.31 | 1.44 | 0.58 | 4.59 |
2019 | 1.17 | 1.22 | 1.29 | 1.54 | 5.22 |
2018 | 1.12 | 1.07 | 1.17 | 1.42 | 4.78 |
2017 | 1.03 | 1.12 | 1.12 | 1.33 | 4.6 |
2016 | 1.02 | 1.03 | 1.06 | 1.27 | 4.38 |
2015 | 0.93 | 0.96 | 1.01 | 1.16 | 4.06 |
2014 | 0.88 | 0.91 | 0.91 | 1.12 | 3.82 |
2013 | 0.85 | 0.88 | 0.93 | 1.1 | 3.76 |
2012 | 0.79 | 0.84 | 0.84 | 0.99 | 3.46 |
2011 | 0.8 | 0.82 | 0.86 | 0.9 | 3.38 |
2010 | 0.79 | 0.77 | 0.77 | 0.9 | 3.23 |
Umsatz pro Jahr & Quartal
Q1 Mai-Jul |
Q2 Aug-Okt |
Q3 Nov-Jan |
Q4 Feb-Apr |
Jahr Mai-Apr |
|
---|---|---|---|---|---|
2021 | 7.493 | 7.647 | 0 | 0 | 15.14 |
2020 | 7.384 | 7.706 | 7.717 | 5.997 | 28.804 |
2019 | 7.384 | 7.481 | 7.546 | 8.146 | 30.557 |
2018 | 7.39 | 7.05 | 7.369 | 8.144 | 29.953 |
2017 | 7.166 | 7.345 | 7.283 | 7.916 | 29.71 |
2016 | 7.274 | 7.058 | 6.934 | 7.567 | 28.833 |
2015 | 4.273 | 4.366 | 4.318 | 7.304 | 20.261 |
2014 | 4.083 | 4.194 | 4.163 | 4.565 | 17.005 |
2013 | 4.008 | 4.095 | 4.027 | 4.46 | 16.59 |
2012 | 3.946 | 4.023 | 3.918 | 4.297 | 16.184 |
2011 | 3.773 | 3.711 | 3.857 | 4.167 | 15.508 |
2010 | 3.951 | 3.838 | 3.85 | 4.196 | 15.835 |
Umsatz je Aktie pro Jahr & Quartal
Q1 Mai-Jul |
Q2 Aug-Okt |
Q3 Nov-Jan |
Q4 Feb-Apr |
Jahr Mai-Apr |
|
---|---|---|---|---|---|
2021 | 5.55 | 5.66 | 0.00 | 0.00 | 210.28 |
2020 | 5.44 | 5.70 | 5.71 | 4.44 | 21.30 |
2019 | 5.40 | 5.48 | 5.54 | 6.02 | 22.58 |
2018 | 5.31 | 5.12 | 5.39 | 6.01 | 22.12 |
2017 | 5.03 | 5.22 | 5.23 | 5.72 | 21.48 |
2016 | 6.56 | 4.92 | 4.85 | 5.32 | 20.28 |
2015 | 4.21 | 4.34 | 4.35 | 7.33 | 20.34 |
2014 | 3.97 | 4.11 | 4.13 | 4.52 | 16.84 |
2013 | 3.78 | 3.95 | 3.92 | 4.37 | 16.25 |
2012 | 3.65 | 3.76 | 3.69 | 4.05 | 15.27 |
2011 | 3.40 | 3.40 | 3.56 | 3.87 | 14.39 |
2010 | 3.51 | 3.44 | 3.47 | 3.78 | 14.28 |
Gewinn-Wachstum in Prozent
Q1 Mai-Jul |
Q2 Aug-Okt |
Q3 Nov-Jan |
Q4 Feb-Apr |
Jahr Mai-Apr |
|
---|---|---|---|---|---|
2021 | -24.61 | 0.41 | -100.00 | 0.00 | -79.62 |
2020 | -26.28 | 57.87 | 40.40 | -66.27 | 3.41 |
2019 | -26.37 | 3.72 | 13.81 | -7.64 | 49.19 |
2018 | -12.64 | 98.52 | -168.86 | 0.00 | -22.94 |
2017 | -15.78 | 20.02 | -26.37 | 41.66 | 13.85 |
2016 | -51.71 | -36.59 | 110.58 | 0.73 | 5.30 |
2015 | 94.42 | -4.94 | -104.48 | 0.00 | 9.62 |
2014 | -1.65 | -5.35 | -15.52 | -41.21 | -11.60 |
2013 | -12.82 | -25.23 | 52.94 | -1.92 | -4.15 |
2012 | 5.80 | 6.09 | 7.23 | 6.10 | 16.83 |
2011 | -13.00 | -31.81 | 63.25 | -16.02 | -0.10 |
2010 | 332.04 | 95.28 | -4.37 | 14.80 | 49.71 |
Umsatz-Wachstum in Prozent
Q1 Mai-Jul |
Q2 Aug-Okt |
Q3 Nov-Jan |
Q4 Feb-Apr |
Jahr Mai-Apr |
|
---|---|---|---|---|---|
2021 | 24.95 | 2.06 | 0.00 | 0.00 | 0.00 |
2020 | -9.35 | 4.36 | 0.14 | -22.29 | -5.74 |
2019 | -9.33 | 1.31 | 0.87 | 7.95 | 2.02 |
2018 | -6.64 | -4.60 | 4.52 | 10.52 | 0.82 |
2017 | -5.30 | 2.50 | -0.84 | 8.69 | 3.04 |
2016 | -0.41 | -2.97 | -1.76 | 9.13 | 42.31 |
2015 | -6.40 | 2.18 | -1.10 | 69.15 | 19.15 |
2014 | -8.45 | 2.72 | -0.74 | 9.66 | 2.50 |
2013 | -6.73 | 2.17 | -1.66 | 10.75 | 2.51 |
2012 | -5.30 | 1.95 | -2.61 | 9.67 | 4.36 |
2011 | -10.08 | -1.64 | 3.93 | 8.04 | -2.07 |
2010 | 3.19 | -2.86 | 0.31 | 8.99 | 8.47 |
Medtronic plc Dividenden-Entwicklung
Ex-Tag | Record Date | Zahltag | Dividende |
---|---|---|---|
2020-12-21 | 2020-12-22 | 2021-01-15 | 0.58 |
2020-09-24 | 2020-09-25 | 2020-10-16 | 0.58 |
2020-06-25 | 2020-06-26 | 2020-07-17 | 0.58 |
2020-03-26 | 2020-03-27 | 2020-04-17 | 0.54 |
2019-12-26 | 2019-12-27 | 2020-01-17 | 0.54 |
2019-09-26 | 2019-09-27 | 2019-10-18 | 0.54 |
2019-07-05 | 2019-07-08 | 2019-07-25 | 0.54 |
2019-03-21 | 2019-03-22 | 2019-04-12 | 0.5 |
2018-12-27 | 2018-12-28 | 2019-01-18 | 0.5 |
2018-09-27 | 2018-09-28 | 2018-10-19 | 0.5 |
2018-07-05 | 2018-07-06 | 2018-07-25 | 0.5 |
2018-03-22 | 2018-03-23 | 2018-04-13 | 0.46 |
2017-12-28 | 2017-12-29 | 2018-01-19 | 0.46 |
2017-09-28 | 2017-09-29 | 2017-10-20 | 0.46 |
2017-07-05 | 2017-07-07 | 2017-07-26 | 0.46 |
2017-03-22 | 2017-03-24 | 2017-04-13 | 0.43 |
2016-12-21 | 2016-12-23 | 2017-01-13 | 0.43 |
2016-09-27 | 2016-09-29 | 2016-10-21 | 0.43 |
2016-07-06 | 2016-07-08 | 2016-07-27 | 0.43 |
2016-03-22 | 2016-03-24 | 2016-04-15 | 0.38 |
Hinterlasse einen Kommentar